A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: against (297)

Finance and Performance Reports 2022-23 Month 2 May 2022

Description
Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addressed: Finance Report 2022
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Finance-and-Performance-Reports-2022-23-Month-2-May-2022.pdf

Papers Trust Board 28 March 2019

Description
Agenda Group Name: Date of Meeting: Venue: Time: Apologies to: Trust Board – Open Session 28 March 2019 Conference Room, Heartbeat Education
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2019/Papers-Trust-Board-28-March-2019.pdf

Epirubicin (7) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (7 day) Regimen Breast Cancer – Epirubicin (7 day) Indication Treatment of locally advanced or metastatic breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin7Ver11.pdf

Epirubicin (21) Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (21 day) Regimen Breast Cancer – Epirubicin (21 day) Indication Treatment of locally advanced or metastatic breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin21Ver11.pdf

Gender Pay Gap Report 2025

Description
Gender Pay Gap. Our Gender Pay Gap at a Glance Snapshot from 31st March 2025 The Context This is the 8th
Url
/Media/UHS-website-2019/Docs/gender-pay-gap-report-2025.pdf

Long-term follow-up (LTFU) clinic (oncology and haematology) - patient information

Description
This factsheet explains what the long-term follow-up (LTFU) clinic is and what will happen at your child's appointments, so
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Long-term-follow-up-LTFU-clinic-oncology-and-haematology-3546-PIL.pdf

Carboplatin-Vinorelbine Oral

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral) Indication  First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Carboplatin (AUC6) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Carboplatin-Vinorelbine-IV-RT

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE-RADIOTHERAPY (Intravenous) Regimen • NSCLC – Carboplatin-Vinorelbine (intravenous)-Radiotherapy Indication • First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-IV-RT.pdf

Carboplatin (AUC5) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf
31 to 40 of 65
Previous … 2 3 4 5 6 … Next